ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 173 filers reported holding ACORDA THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $1,837,000 | -47.7% | 69,300 | -34.2% | 0.16% | -45.1% |
| Q2 2015 | $3,510,000 | +70.6% | 105,300 | +70.4% | 0.30% | +68.6% |
| Q1 2015 | $2,057,000 | +87.9% | 61,800 | +64.8% | 0.18% | +59.1% |
| Q4 2013 | $1,095,000 | +378.2% | 37,500 | +459.7% | 0.11% | +307.4% |
| Q3 2013 | $229,000 | – | 6,700 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 428,000 | $8,046,000 | 1.90% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,532,067 | $85,203,000 | 1.61% |
| DLD Asset Management, LP | 247,300 | $4,656,000 | 1.52% |
| Broadfin Capital, LLC | 644,153 | $12,110,000 | 1.34% |
| Perceptive Advisors | 720,000 | $13,536,000 | 0.96% |
| DLD Asset Management, LP | 135,493 | $2,547,000 | 0.83% |
| Malaga Cove Capital, LLC | 51,013 | $971,000 | 0.64% |
| Baker Brothers Advisors | 3,301,791 | $62,074,000 | 0.61% |
| Worth Venture Partners, LLC | 29,300 | $551,000 | 0.59% |
| Spark Investment Management LLC | 327,900 | $6,164,000 | 0.51% |